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Abstract  
This project uses the nematodes C.elegans and C.briggsae as simple experimental 
systems to identify new tumor suppressor genes and to understand how these influence cell 
signaling and cell division. Comparisons between the two species will allow us to better 
understand how genetic backgrounds can influence the function of tumor suppressor genes. 
Tumor suppressor genes normally prevent inappropriate cell division and loss-of-function 
mutations in these genes are associated with cancer. Our lab has identified new mutants in 
C.briggsae that exhibit a multivulva phenotype and in preliminary results I have found that one 
of these genes is Cbr-gon-14.  In C.elegans, gon-14 encodes a nuclear protein that influences 
gonad development but has only a modest impact on vulva cell development. Thus, we have 
identified that this is a novel tumor suppressor gene that influences cell division differently in the 
distinct genetic backgrounds represented by the two species. To identify the mutation associated 
with the C.briggsae mutant allele, I completed DNA sequencing studies using the C.briggsae 
mutant strain we had in the lab. I found two alleles for the C.briggsae gon-14 gene. I completed 
cDNA amplification of the entire gene to verify the structure of the gene. In addition, I also 
completed a cDNA amplification of the Cbr-gon-14 worms grown at 25°C. These animals 
showed the mutation that was expected for the Cbr-gon-14 mutants. I also completed a 
temperature shift experiment to determine the temperature sensitive period of the Cbr-gon-14 
mutants. The results of these studies aid in the identification and genetic characterization of a 
new tumor suppressor gene in C.briggsae animals. Comparing the genetic backgrounds between 
the C.elegan and C.briggsae gon-14 gene will aid in the understanding of how different genetic 
backgrounds influence the function of tumor suppressor genes.  
 
 
Introduction 
 
This project focuses on the study of vulva development in nematodes C.elegans and 
C.briggsae to understand and compare the molecular networks between the two species. We use 
these two nematode species because they both exhibit similar patterns of development, 
morphogenesis and cell differentiation resulting in similar phenotypic outcome (Gupta et al. 
2007; Zhao et al. 2010; Sharanya et al. 2012). However, the genetic pathways underlying this 
similar phenotypic outcome between the two species are not well understood.  
In both C.elegans and C.briggsae, the vulva is made from the division of Vulval 
Precursor Cells (VPC’s). There are three types of cell fates that are produced once the anchor 
cell (AC) initiates the cell signaling. There is primary cell fate (1°), secondary cell fate (2°) and 
tertiary cell fate (3°). The cell just below the anchor cell, P6.p, adopts a primary cell fate. The 
two cells neighboring P6.p, -P5.p and P7.p- become secondary cell fate. The rest of the cells, 
P3.p, P4.p, and P8.p, become tertiary cell fate (Figure 1).  
The way this egg-laying structure works is that the Anchor Cell secretes a signal (LIN-
3/EGF) that activates a cascade of events in the VPC’s resulting in the vulva development. The 
LIN-3/EGF (Epidermal Growth Factor) and LIN-12/Notch pathways are important pathways that 
regulate cell division and cell growth.  These pathways are conserved in nematodes, and are 
important for regulating cell division of ventral epithelial cells during development of the vulva 
(Figure 2). The LIN-3/EGF pathway mediates induction of the nematode vulva (Sternberg and 
Horvitz, 1991) and the LIN-12/Notch pathway mediates lateral signaling between vulva 
precursor cells to allocate precursors to specific vulva fates (Greenwald et al., 1983). 
 
 	
 
Figure 1: Shows vulva development in both C.elegans and C.briggsae and the phenotypic 
differences between wild-type and multivulva animals (Weidhaas, J. 2006) 
 
	
	
Figure 2: The LIN-3/EGF signaling cascade regulates cell division and growth in both C.elegans and 
C.briggsae animals. 	
Mutations within the LIN-3/EGF cell-signaling pathway can change the phenotype of the 
animal. My research focuses on mutants that show the Multivulva (Muv) phenotype.  Mutant 
worms that show the Muv phenotype have more VPC’s dividing than normal (Figure 1). 
Animals showing the Muv phenotype exhibit inappropriate division of distal VPC’s and 
therefore these mutants identify tumor suppressor genes (Sharanya et al. 2015).  
Our lab has identified new mutants in C.briggsae that exhibit this Muv phenotype. My 
research objective is to identify and characterize one of these mutant genes represented by the 
alleles gu102 and gu168. I show that these mutations are in the C.briggsae gon-14 gene. This 
work argues that gon-14 is a novel tumor suppressor gene in nematode species C.briggsae.  
 The C.briggsae gon-14 gene is an ortholog of the C.elegans gon-14. In C.elegans the 
gon-14 gene is involved in gonad development, muscle contraction and multicellular organism 
growth, among other functions (Mulder et al., 2013). Loss of function of this gene causes 
multiple phenotypic expressions such as Muv defects and temperature sensitive larval arrest 
(Chesney et al., 2005).  
When we compared the VPC induction between C.elegans and C.briggsae gon-14 
mutants, average induction is higher in C.briggsae animals arguing that the EGF signaling 
network in C.briggsae is more sensitive than in C.elegans  (Figure 3) (Sharanya et al. 2015). 
	
Figure 3: Comparison of the percent induction of Vulva Precursor Cells between C.elegans gon-14 
mutants and C.briggsae gon-14 mutants (Sharanya et al. 2015). 
To further understand this novel tumor suppressor gene I did a complete DNA 
sequencing analysis using the C.briggsae mutant strains we had in the lab. Then, to corroborate 
the entire gene structure I completed a full cDNA amplification of the entire gene. In addition, I 
completed temperature shift experiments to identify the temperature sensitive period of these 
mutants since previous studies suggest that C.briggsae gon-14 mutants are temperature sensitive. 
Altogether, the results of this research will help the understanding of the novel tumor suppressor 
gene gon-14 in C.briggsae animals.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Materials and methods 
Strains  
The Multivulva mutants used in these experiments were generated from a genetic screen by 
mutagenizing AF16 animals in a 25mM M9 buffer solution of Ethyl Methane Sulfonate (EMS) 
(Sharanya 2015). Dr. Helen Chamberlin generated the C. briggsae gu102 and gu168 mutant 
strains from a genetic screen. The C.briggsae wild-type strain used was AF16.  
 
DNA sequencing  
I used DNA sequencing methods to determine the DNA mutation associated with particular 
mutant candidates Cbr-gu102 and Cbr-gu168. To find the mutation in the two candidates I 
prepared genomic DNA from each strain. Mixed staged animals were harvested using standard 
methods (Brenner 1974). Then I used PCR to amplify sections of the gon-14 gene from the 
mutant DNA. Samples were digested using pBII (pBluescript) as the cloning vector, and the 
XhoI and SacI enzymes were used. Samples were then heat inactivated, the vector was 
dephosphorylated and samples were ligated and transformed. The Plant-Microbe Genomics 
Facility at The Ohio State University sequenced the PCR products.  
DNA sequencing using the Sanger method: Sanger sequencing technique is one of the 
most commonly used methods for DNA sequencing of recombinant plasmids. Employing 
the Sanger Sequence protocol involves using DNA polymerase, designed primers 
(forward and reverse primers), unlabeled deoxynucleotide triphosphates (dNTPs) and the 
template DNA (NEB, 2016). 
- DNA was isolated from the samples of interest.  
- Then we amplified the DNA region of interest by using PCR. This region of 
interest was selected from primers that I designed with Dr. Chamberlin’s 
assistance. These primers are listed on Table S1.  
- Products were generated by cycle sequencing and then purified using QIAquick 
PCR Purification kit and manufacturer’s protocol (QIAGEN, 2013). 
- Products were analyzed using gel electrophoresis.  
 
cDNA amplification 
C.briggsae gon-14 cDNA was sequenced to identify exon boundaries. RNA was extracted from 
animals in mixed stages grown at both 20°C and 25°C using the TRIzol Reagent (Invitrogen, 
USA). RNA concentration was measured using absorption spectrometry. mRNA was reverse 
transcribed using random primers and cDNA was amplified using PCR. For cDNA synthesis,  
1ul of RNA was reverse transcribed by using SuperScript III Reverse Transcriptase (SSIII) 
following the manufacturer’s instructions (Invitrogen, USA). RT-PCR products were purified 
and then sequenced. C.briggsae gon-14 animals grown at 25°C were sequenced to determine if 
the temperature affected the mutation. The primers used for the cDNA amplification are listed on 
Table S1. 
TRIzol Reagent Method (Invitrogen, USA): RNA was extracted following the manufacturer’s 
instructions.  
RNA collection:  3 units of TRIzol were added for every 1 unit of sample. Samples were 
frozen at -80°C for at least 3 hours.  
Phase separation: chloroform was added, samples were incubated and centrifuged. The 
upper aqueous phase was pipetted out. The aqueous phase was used for the next stages. 
RNA precipitation: Isopropanol was added, samples were incubated at room temperature  
and centrifuged at 4°C. 
RNA wash: The supernatant was removed and the RNA pellet was left. The pellet was 
washed with 75% ethanol. Samples were vortex, centrifuged at 4°C and the wash was 
discarded. RNA pellet was air dried.  
RNA resuspension: The RNA pellet was resuspended in RNase-free water and incubated 
in a water bath. RNA was stored at -80°C. 
 
Temperature Shift Experiment 
Previous data from Dr. Chamberlin’s laboratory shows 
that the C.briggsae gu102 mutant strain is temperature 
sensitive (Figure 4). Gravid adult worms were treated 
with bleach to isolate embryos (Lewis and Fleming, 
1995). The embryos were incubated in M9 buffer without 
food (Brenner, 1974) at room temperature for 16-18 
hours for AF16, and 22-25 hours for gon-14 mutants to hatch and arrest at the L1 stage. The 
synchronized L1 larvae were set in NGM plates.  The staging was determined by examining 
animals under the microscope. After we synchronized the animals we started the experimental 
set up. One group had an initial temperature of 20°C (restrictive temperature) and the other group 
had an initial temperature of 25°C (permissive temperature). The control group stayed at the 
initial temperature throughout the course of experiment and the experimental group shifted to the 
opposite temperature condition after 0, 6, 12, 18, 24 hours respectively. Phenotypic data was 
collected two days after the shift.  
Strain Temperature % Muv 
C.briggsae 
gon-14 
25ºC 3.2% 
20ºC 96.9% 
15ºC 97.8% 	
Figure 4: Shows the data collected by 
Dr. Chamberlin of percent Muv of the 
C.briggsae gon-14 worm at 25°C, 20°C 
and 15°C (Sharanya et al., 2015) 
 
Results 
 
Identification of the mutations associated with two C.briggsae gon-14 alleles 
Two candidates were selected from the genetic screen that Dr. Chamberlin did to identify 
Multivulva mutants. The two candidates are Cbr-gu102 and Cbr-gu168. These two mutations fail 
to complement each other, indicating they are alleles of the same gene (Sharanya et al., 2015). 
Cbr-gu102 was genetically mapped to C.briggsae chromosome 5 (Sharanya et al., 2015). In 
preliminary results, a whole genome sequencing analysis of genomic DNA from Cbr-gu102 
identified a number of mutations on chromosome 5, including one in the C.briggsae gon-14 
gene. I sought to identify the mutation associated with the mutant allele carrying out sequencing 
of genomic DNA from both gu102 and gu168 strains. This sequencing demonstrated that we 
have two alleles for the gon-14 gene in the lab.  
Both alleles have a point mutation. The gu102 allele has a point mutation that affects the 
splice site at the 5’ end of intron 5 (G to A) (Figure 5A).  The gu168 allele has a point mutation 
that affects the splice site at the 5’ end of intron 4 (C to T) (Figure 5B).  
- The gu102 mutation is designated in red bold: 
ACAATTGAATATATACGAAAATTGTTTCAAACGAATCTGAATA 
- The gu168 mutation is designated in blue bold:  
ACATGCATTGACTGTTCAGTGATT 
The point mutation in both alleles causes the introduction of a premature stop codon in the 
transcribed mRNA. The codons of the mRNA located after the stop codon are not translated 
because the nonsense codon in the mRNA is reached too early during the translation of the 
protein. This in turn causes the production of a nonfunctional protein codon.  
After we identified the mutation we sought to understand how the mutation was changing 
the gene product (Figure 6). We predicted that the gu102 mutation would result in a failure of 
intron 5 to be removed from the mRNA. Conceptual translation of the resulting sequence 
predicts that the mutation would cause the introduction of an intron between exon 5 and 6 and 
insert a premature stop codon. We confirmed the splicing defect using RT-PCR on RNA from 
gu102 mutants. The results of this amplification showed that indeed the introduction of the 
mutation causes the inclusion of an intron between exon 5 and exon 6 in mature mRNAs. 
 
 
                
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
 
 
 
 
Figure 5: Shows the DNA alignment of C.briggsae wild type and mutant sequences. C.briggsae 
gu102 allele and its respective mutation is shown at the top-right. C.briggsae gu168 allele and its 
respective mutation is shown at the bottom-left of the figure. (Wormbase) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Shows the cDNA sequence of the C.briggsae gon-14 wild type and mutant. The 
picture on the left shows the normal cDNA sequencing. The picture on the right shows how the 
cDNA sequence changes because of the introduction of the mutation. The mutation causes the 
addition of an intron and a stop codon. 
	
	
	
A.	
B.	
The temperature sensitive nature of gu102 does not result from a temperature sensitive splicing 
defect 
RNA splicing requires complex biochemical process including the making and breaking 
of base pairs between RNAs (Lodish H. et al., 2000). Thus, I hypothesized that the cold sensitive 
nature of the gu102 mutation might result because the intron was spliced successfully. To test 
this hypothesis, I purified RNA from gu102 animals raised at 20°C (restrictive) and 25°C 
(permissive) temperatures.  
C.briggsae gon-14 animals grown at 25°C showed the splicing of intron 5 was the same 
for the RNA from animals grown at 20°C. These results suggest that the high temperature is not 
altering the expression of the mutation or the protein splicing. 
- The sequence of the C.briggsae gon-14 animals grown at 25°C is:  
ATATatgcgaaaattgtttcaaacgaatctgaatata 
     * 
 
I also purified RNA from wild type animals raised at 20°C to confirm the Cbr-gon-14 
gene structure. cDNA amplification of the wild-type C.briggsae gon-14 gene from animals 
grown at  20°C confirmed the gene structures predicted in Wormbase (www.wormbase.com) 
(Figure 7).  
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Shows the comparison between the wild-type and C.briggsae gon-14 mutant 
sequences for all 13 exons. Red numbered row shows a model of the unspliced coding sequence 
of 13 exons.  First column on the left shows exons 1-7 and the column on the right shows exon 
7-13. Each boundary was verified with the gene structures predicted in Wormbase. 
 
C.briggsae gon-14 mutants are temperature sensitive and the Multivulva proportion is different 
between worms grown at 20°C and 25°C 
 
 We hypothesized that gon-14 is temperature sensitive and it is required to prevent 
excessive cell division. To test this hypothesis we performed a temperature shift experiment to 
determine. The purpose of this experiment is to determine the temperature sensitive period of the 
C.briggsae gon-14 mutants. In this experiment we had both a control and experimental set up. In 
the control group, the upshift worms stayed at 25°C and the downshift worms stayed at 20°C 
throughout the experiment. In the experimental group, the upshift worms started at 20°C and 
were shifted to 25°C and the downshift worms started at 25°C and were shifted to 20°C . 
 The results of this experiment confirm previous studies that showed that there is a 
difference between the proportions Muv of the worms when grown at the two different 
temperatures. The results in Figure 8 show that the upshifted worms display an overall increase 
in the proportion Muv, whereas the downshifted worms show slight decline overtime. The results 
presented in Figure 9 show the same overall increasing pattern of the upshifted worms (similar to 
what is seen in Figure 8. However, when we look at the downshifted worms, we see a steep 
decrease at hour 6 but a steady increase in the proportion Muv after that.  
The results of this experiment are ambiguous. Thus, to improve the results the next step 
would be to repeat the experiment again to corroborate and clarify the results. In addition, we 
should add more time points to the experiment (i.e. 28, 30, 32, 41 hours). This will give us a 
better perspective of the overall proportion Muv patterns overtime.  
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	
	
Figure 8: shows the data collected on 
the first trial for the temperature shift 
experiment.	
Figure 9: shows the data collected on 
the second trial for the temperature 
shift experiment.	
Discussion 
  
Tumor suppressor genes are still an enigma within the scientific community. 
Understanding how these genes work will help aid in the understanding of cancer development. 
Nematodes, such as C.briggsae animals are great model organisms to study tumor suppressor 
genes. In this work, we identified and characterized a new tumor suppressor gene called 
C.briggsae gon-14 gene. There are three main points to take away from this research.  
First, the mutation associated with the two C.briggsae gon-14 alleles was identified. 
Sequencing results demonstrated that we have two alleles for the gon-14 gene in lab. Both alleles 
have a point mutation that causes the addition of an intron and the introduction of a premature 
stop codon. Consequently, this causes the production of a truncated protein and the protein’s 
failure to splice.  
Second, in gu102 animals, temperature is not affecting the expression of the mutation or 
the protein splicing. The RNA making process is very complex. Temperature could be a factor 
that potentially affects this process. However, when we looked at C.briggsae gon-14 animals 
grown at 25°C and compared these to C.briggsae animals grown at 20°C we see that both 
showed the splicing of intron 5. These results suggest that high temperatures is not affecting the 
RNA making and breaking process thus, it is not altering the expression of the mutation or the 
protein splicing. In addition to studying the temperature sensitivity of the gu102 animals I also 
confirmed the C.briggsae gon-14 gene structure. We amplified wild-type C.briggsae gon-14 
cDNA from animals grown at 20°C and we confirmed the exon boundaries of all 13 exons in the 
gene by comparing it with the gene structures predicted in Wormbase. 
Third, we verified that the C.briggsae gon-14 mutants are temperature sensitive and that 
the Multivulva proportion between worms grown at two different temperatures is different.  Our 
results show that there is indeed a difference between the Multivulva proportion of the worms 
grown at two different temperatures but we could not pinpoint the specific time in development 
when the gon-14 gene function is required in development. However, when we compare our 
temperature shift experiment data to Sharanya’s et, al., 2015 data we do not see quite the sharp 
difference in terms of proportion Muv. This could be due to many different factors including the 
different experimental approaches taken.  
The next step to further understand this tumor suppressor gene could be a profound study 
of its RNA using RNA sequencing. This method will unveil the presence and quantity of RNA at 
a given point in development. RNA sequencing will help us understand if the gene is tissue 
specific and if the gene expression changes across time. Altogether, this information will help us 
understand how tumor suppressor genes work and their involvement in cancer development.  
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Supplementary Table 1 
 
Primers Table 
Primers Sequence (5’ →  3’) Purpose 
genDNA A AGAACCGTTGGAAGCTACGAG DNA sequencing 
genDNA B  TTGTGACTGGAAAGGCCGAG DNA sequencing 
genDNA C GCACTCATCGAATCACGAAGG DNA sequencing 
genDNA D GATCCGTGTTGGTAGTTCATCTTC DNA sequencing 
genDNA E GCTCTGTTCCTCCATCCTCG DNA sequencing 
genDNA F TTCGTCCAACATTCTGATCCTC DNA sequencing 
genDNA G ATCCCGCGCAGGTAGTTCTC DNA sequencing 
genDNA H AATGGGCCATGAAGTGTGACTTG DNA sequencing 
genDNA I  GTCACACTTCATGGCCCATTTC DNA sequencing 
genDNA K  GTCGTCCCGTCCAACTTCAG DNA sequencing 
genDNA L TCTACAGTAATCTTCGCAAGCGTC DNA sequencing 
genDNA M CTGAAGTTGGACGGGACGAC DNA sequencing 
genDNA N CGCTTGCGAAGATTACTGTAG DNA sequencing 
genDNA O GAATGAGAACTGGGAGAAAGTCG DNA sequencing 
genDNA P AGGAGAAGTGATAGGGAAAGGAAG DNA sequencing 
cDNA 1 CTATTGTGACTGGAAAGGCCGAG cDNA amplification 
cDNA 2 AGAACCGTTGGAAGCTACGAG cDNA amplification 
cDNA 3 GTAGCCGTGGAAAGCGAGTC cDNA amplification 
cDNA 4 TGCTGATCCGTGTTGGTAGTTC cDNA amplification 
Exon 1-2 A TCCATCCACATCAAAGCCGAAC cDNA amplification 
Exon 1-2 B CCCAGAGTTGTCTGATTGTGAAG cDNA amplification 
Exon 2 A AAATTCAACCAGATAATGGCCCAG cDNA amplification 
Exon 2 fw A CTTTCTGGCGTTCTCTGTTC cDNA amplification 
Exon 2 fw B TTCGACACTACATCATTCAACAATC cDNA amplification 
Exon 2 B TCAACCAGATAATGGCCCAGTG cDNA amplification 
Exon 4 rv A CTGGCTGACGAAATCACTGAAC cDNA amplification 
Exon 4 rv B TGGATATTCTCCGTAGGTTCG cDNA amplification 
Exon 4 rv C TGTTCGAGTTCAGAAGCTGG cDNA amplification 
Exon rv D TGATAGCGGGAATGACATCG cDNA amplification 
Exon rv E AGAAGCAAACGATTGAAGAGC cDNA amplification 
Exon rv F GATCAGAATGTTGGACGAATGG cDNA amplification 
Exon 6 1.1 TTCCCGCTATCATGGAGTTG cDNA amplification 
Exon 6 1.2 TCAGTGATTTCGTCAGCCAG cDNA amplification 
Exon 6-7 junction GCACATTATATCTCCCTTGGCTCG cDNA amplification 
Exon 9 fw A TGATGTGAGCAAGGCTGTTAG cDNA amplification 
Exon 9 fw B CCATTGACGCTTCTTTCTATTTAGG cDNA amplification 
Middle fw A ATACTGCAATCGACCCGAAAGG cDNA amplification 
Middle fw B TTCGAGCCAAGGGAGATATAATGTG cDNA amplification 
End rv A ATTGGTGGTTTATGTATCTGATGTG cDNA amplification 
End rv B CATCGTTCTGACTGCGTAATACTTC cDNA amplification 
Exon 13 rv   ATACACCTTTTTCGATGCTGCC cDNA amplification 
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